{"id":"NCT00000135","sponsor":"Johns Hopkins Bloomberg School of Public Health","briefTitle":"Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT)","officialTitle":"Monoclonal Antibody CMV Retinitis Trial (MACRT)","status":"COMPLETED","phase":"PHASE2","dates":{"start":"1995-09","primaryCompletion":"1996-08","completion":"1996-08","firstPosted":"1999-09-24","resultsPosted":"2015-11-17","lastUpdate":"2015-11-17"},"enrollment":209,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["HIV Infections","Cytomegalovirus Retinitis"],"interventions":[{"type":"DRUG","name":"MSL-109","otherNames":["Monoclonal antibodies"]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"MSL-109","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"To evaluate the efficacy and safety of a human anti-CMV monoclonal antibody, MSL-109, as adjunct therapy for controlling CMV retinitis.","primaryOutcome":{"measure":"Mortality Rate","timeFrame":"All patients enrolled were followed for a 17 month period or until a common study closing date","effectByArm":[{"arm":"MSL-109","deltaMin":0.68,"sd":null},{"arm":"Placebo","deltaMin":0.31,"sd":null}],"pValues":[]},"eligibility":{"minAge":"13 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":4},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["9400786","11919489","12232843","12559647","31042791"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":104},"commonTop":[]}}